New Biotechnology Businesses in Manhattan, NY

Allogenetics Inc. is a biotechnology company based in Manhattan, New York, focused on developing a novel approach to prevent organ rejection by inducing immunological invisibility in donor organs rather than suppressing the recipient's immune system. The company's website describes a vision of solving organ rejection through this alternative strategy, and the business operates from an address at 120 Wall Street, 20th Floor, New York, NY 10005.

The website's domain directly matches the LLC name KHORA TX, and the filing lists a principal address in Manhattan, NY. The site appears to be the online presence of a small biotech company focused on cancer treatments.

MBrace Therapeutics is a clinical-stage biopharmaceutical company focused on translating innovative antibody-drug conjugate (ADC) discoveries into transformative therapies. The company's website highlights core values of compassion, discovery, innovation, and determination, and provides contact emails for partners and legal inquiries. The site lists a San Diego, CA business address.

Leal Tx is a biotech startup focused on developing metabolic therapies to restore brain health, with clinical trials for conditions like schizophrenia and ALS. The company recently raised $30M in Series A funding, as reported in news articles. Its website lists a location in Worcester, MA, while the LLC filing shows a Manhattan, NY address for incorporation.

Proxima Bio is a biotechnology company based in New York, NY, focused on decoding and programming protein interactions to develop proximity-based medicines. The company recently raised $80 million in funding, as reported in a press release. Its website details a mission to unlock new chapters in medicine by making protein interactions programmable, with a team and contact information in Manhattan.

Superluminal Medicines is a generative biology and chemistry company focused on accelerating drug discovery and development. Their Hyperloop™ platform integrates structure-based drug discovery with machine learning. The company has raised significant venture capital, including a $120 million funding round led by RA Capital Management, and is based in Boston, MA. The website and news articles confirm their active operations and scientific focus.

Basking Biosciences is a biotechnology company focused on developing reversible therapies targeting von Willebrand Factor for acute thrombotic conditions. The website emphasizes precision control for safer treatment. The business appears to be a clinical-stage biotech firm based in the United States.

Buckle Therapeutics appears to be a biotechnology or therapeutics company, as indicated by its corporate name and domain name. No further details are available from the provided data.

The website lists an address in Irvine, CA, and a toll-free phone number. The LLC filing in New York suggests a registered presence, possibly for administrative purposes.

Le Bio Roux Inc. is listed as a corporate member of NewYorkBIO, a biotechnology industry association, indicating it operates in the biotech sector in New York. The LLC's principal address is 40 Ann Street, Manhattan, NY.

Zydus Therapeutics Inc. is a biopharmaceutical company based in Pennington, NJ, focused on developing life-changing therapies. The website highlights their pipeline and dedication to patient care, with contact information matching the LLC's name and industry.

Spore.Bio is a biotechnology company applying AI and photonics to accelerate microbiology testing, particularly in food safety. The company's website (spore.bio) promotes its technology and impact. News articles confirm a $23M Series A funding round.

Argo Biopharma is a biopharmaceutical company established in April 2021, focusing on developing a new generation of siRNA drugs for chronic diseases. It was founded by returnee scientists with experience in siRNA drug development and has entered multi-asset license agreements with Novartis.

LeonaBio is a publicly traded biotechnology company (NASDAQ: LONA) headquartered in Bothell, WA, developing new therapies for patients. The website lists clinical trials and product candidates. The LLC filing in New York likely represents the corporate entity.

AADI Bioscience is a commercial-stage biopharmaceutical company focused on developing therapies for difficult-to-treat diseases, primarily through mTOR inhibition. The company recently rebranded to Whitehawk Therapeutics. The website and press releases confirm its active operations.

GenKardia is a biotechnology startup based in New York City, focusing on developing therapies to keep the heart young. The website highlights their mission, team, pipeline, and news, suggesting active drug development.

Alpheus Medical is a biotechnology company developing a novel drug-ultrasound combination therapy for solid tumors, focusing initially on glioblastoma. The company is based in Chanhassen, Minnesota, and recently raised $52M in Series B funding. The website provides information about their technology, clinical trials, and company news.

Nionyx Bio is a biotechnology company developing gene therapies for kidney diseases using a proprietary AAV capsid platform. The filing address in Manhattan, NY is consistent with the business's likely headquarters.

FELIQS is a biotechnology company developing first-in-class small molecule therapeutics targeting ferroptosis for ophthalmology, with preclinical and IND-enabling programs, as per its website and news articles.

Alumis Inc. is a publicly traded biotechnology company developing targeted therapies for immune-mediated diseases. The website emphasizes a precision approach to replace broad immunosuppression, with a pipeline built through a merger with Acelyrin. Contact information includes a South San Francisco phone number and a New Jersey address, consistent with a biopharma firm.

Create Medicines is a biotechnology company based in Cambridge, MA, focused on developing in vivo immune cell programming therapies using RNA and lipid nanoparticle (LNP) delivery for cancer, autoimmunity, and fibrosis. The company's website and news coverage confirm active operations and recent rebranding from Myeloid Therapeutics.

NAMINA BIO CORP. is a biotechnology company based in New York, as evidenced by its corporate membership in NewYorkBIO, the state's bioscience industry association (source: NewYorkBIO membership directory). The company has also participated in Deep Tech Week, a conference for deep technology startups (source: event page). Its filing address is in Manhattan, New York.

Valorum Biologics (likely the operating name) develops and commercializes high-value biosimilars for niche markets and serious diseases. The company is headquartered at 555 Madison Avenue, New York, NY, matching the LLC filing address.

Valorum Biologics develops and commercializes high-value biosimilars for niche markets and serious diseases, including ophthalmology and oncology. The company is located at 555 Madison Avenue, New York, NY, matching the LLC's principal address.

Valorum Biologics develops and commercializes high-value biosimilars for niche markets and serious diseases. The company operates from 555 Madison Avenue, New York, matching the LLC's principal address. The LLC 'Valorum Holdings' likely functions as the parent holding entity for this biotechnology firm.

The LLC's principal address is a corporate office in Manhattan, while the website's phone numbers are based in North Carolina, suggesting a holding or operational separation.

Second Life Therapeutics is a biotechnology company focused on developing treatments for difficult-to-treat and refractory solid tumors, including cancers once considered untreatable. The company operates from an office in New York, New York, and provides a contact phone number and email for clinical inquiries.

Mixolydian is a biotechnology company focusing on DNA deconvolution, described as the 'next generation' in DNA analysis. The website (mixolydian.co) presents it as a breakthrough in DNA analysis technology. No physical address is listed on the site, but the LLC filing shows a Manhattan address.

Crossbow Therapeutics is a biotechnology company developing novel antibody therapeutics for cancer treatment, with a focus on TCR-mimetic antibodies. The website describes their mission to expand the reach of antibody therapies. The company has raised $77 million in Series B financing as reported in recent news.

Infinite Genomics is a molecular diagnostics laboratory based in North Little Rock, Arkansas, offering rapid pathogen detection services. Their website emphasizes next-day results and serves healthcare providers. The LLC was filed in New York, possibly as a holding or expansion entity.

Anvia Therapeutics is a biotechnology company based in New York, focused on transforming the standard of care in immunology. Their website details their science and team, with a principal address at 345 Park Avenue.

Unicycive Therapeutics is a public biotech company developing therapies for chronic kidney disease, including a phosphate binder for hyperphosphatemia. The website provides detailed information about their pipeline, investors, and corporate communication.

GEDNASA LLC is a biotech company offering AI-powered precision medicine and multi-omics-driven molecular diagnostics.

Arctic Capture is a biotechnology company that uses genetically engineered bacteria and advanced robotics to capture carbon dioxide from the atmosphere.

Remunix, Inc. is a biotechnology company developing novel therapeutics for autoimmune diseases. The website describes its focus on fundamental biology of immune cells. The company's address is in Manhattan, NY.